An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome by Wirth, K.J. et al.
Wirth et al. Journal of Translational Medicine          (2021) 19:471  
https://doi.org/10.1186/s12967-021-03143-3
REVIEW
An attempt to explain the neurological 
symptoms of Myalgic Encephalomyelitis/
Chronic Fatigue Syndrome
Klaus J. Wirth1* , Carmen Scheibenbogen2 and Friedemann Paul3 
Abstract 
There is accumulating evidence of endothelial dysfunction, muscle and cerebral hypoperfusion in Myalgic Encepha-
lomyelitis/Chronic Fatigue Syndrome (ME/CFS). In this paper we deduce the pathomechanisms resulting in central 
nervous pathology and the myriad of neurocognitive symptoms. We outline tentative mechanisms of impaired 
cerebral blood flow, increase in intracranial pressure and central adrenergic hyperactivity and how they can well 
explain the key symptoms of cognitive impairment, brain fog, headache, hypersensitivity, sleep disturbances and 
dysautonomia.
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Introduction
Myalgic Encephaloymelitis (ME/CFS) or Chronic Fatigue 
Syndrome is a frequent and debilitating but still enig-
matic disease. It presents with a confusing variety of 
symptoms ranging from neurological symptoms, fatigue, 
exertional intolerance with post-exertional malaise 
(PEM), chronic muscle pain, skeletal muscle and cardio-
vascular findings to complaints arising from many other 
organs [7]. No effective treatment exists so far. ME/CFS 
is often triggered by infections with various viruses, like 
EBV, enteroviruses, influenza virus, dengue fever and as 
a recent example Corona virus (SARS-CoV2) [17, 18]. 
Very recent studies into post-Covid-19 syndrome (PCS) 
suggest that there is a broad overlap in symptomatology 
between both conditions [17, 21, 24, 25, 32, 41].
ME/CFS is classified as a neurological disease. This 
is based on neurological symptoms including men-
tal fatigue, impaired cognition, psychomotor slowing, 
disturbed sleep, hypersensitivities to noise, light and 
smells, headache, pain and paresthesias and severe 
dysautonomia.
Many symptoms are, however, not obviously explained 
by neurological pathology including the cardiovascular 
situation with orthostatic intolerance, hypovolemia and a 
low activity of the renin–angiotensin–aldosterone system 
(RAAS), or the impaired muscle function (reduced hand-
grip strength and fatigability) and energetic disturbance. 
This co-occurrence of seemingly unrelated symptoms 
and findings prompts to look for a unifying explanation 
(the most parsimonious explanation).
In a first hypothesis paper initially stimulated by the 
finding in ME/CFS patients of autoantibodies against 
ß2-adrenergic receptors (ß2AdR) we hypothesized that 
ß2AdR dysfunction could be of critical importance in 
the pathophysiology of ME/CFS [39], see Textbox 1). We 
described a disturbed interaction between the cardiovas-
cular system and the skeletal muscle, where dysfunction 
of vascular and cardiac ß2AdR together with endothelial 
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Textbox 1 [39]
Pathophysiology of ß2‑adrenergic receptor, vascular 
dysfunction and hypoxemia
• ß2AdR dysfunction could be of critical importance 
in the pathophysiology of ME/CFS potentially caused 
by dysfunctional autoantibodies against ß2AdR, 
polymorphisms and desensitization of ß2AdR by 
(chronic) high sympathetic tone.
• Endothelial or vascular dysfunction, to which dys-
functional ß2AdR contributes, together with a high 
sympathetic tone may lead to an excessive vasocon-
strictor stimulus in skeletal muscles.
• Muscular hypoperfusion stimulates generation of 
endogenous algesic vasodilators as a compensatory 
mechanism that is strongly favored by the poor back-
ground energetic situation in skeletal muscle which 
itself is due to a still enigmatic metabolic disturbance 
(probably a mitochondrial disturbance) [11].
• Spillover of such excessively generated algesic vaso-
dilators into the circulation could explain the cardio-
vascular situation causing hypovolemia, mainly by 
the renal effects, the renin paradoxon (low renin) and 
preload failure further raising sympathetic (vasocon-
strictor) tone.
• The appearance of algesic vasodilators in the systemic 
circulation may explain many of the enigmatic symp-
toms of ME/CFS including pain, hyperalgesia, intes-
tinal complaints, flu-like symptoms, edema and sore 
lymph nodes.
In a second paper we tried to explain the potential 
causes of the energetic disturbances in skeletal mus-
cle, where again, dysfunctional ß2AdR could play a 
key role via the need for ß2AdR-mediated stimula-
tion of the  Na+/K+-ATPase during exercise, which 
is a critical transport system for skeletal muscle 
metabolism [40].
Textbox 2 [40]
Pathophysiology of skeletal muscle disturbances
• ß2AdR stimulates the  Na+/K+-ATPase in skeletal 
muscles. Appropriate muscular perfusion as well as 
function of the  Na+/K+-ATPase determine muscle 
function.
• Dysfunction of ß2AdR leads to an insufficient stimu-
lation of the  Na+/K+-ATPase causing sodium over-
load which reverses the transport direction of the 
sodium-calcium exchanger (NCX) importing calcium 
instead of exporting.
• The ensuing calcium overload affects the mitochon-
dria, cytoplasmatic metabolism and the endothelium 
which further worsens the energetic situation.
• In poor energetic situations increased proton produc-
tion raises intracellular sodium via the sodium-proton-
exchanger subtype-1 (NHE1) in skeletal muscle.
• Calcium overload and impaired energy metabolism 
explain postexertional malaise, exercise intolerance and 
chronification.
The aim of the present hypothesis paper is to pro-
pose causes of the frequent neurological symptoms 
in ME/CFS, and how the previously identified patho-
mechanisms could also translate into the neurological 
symptoms, that we have not addressed so far. In our 
unifying hypothesis of the pathophysiology of ME/
CFS and the pathophysiology of the skeletal mus-
cle disturbances [39, 40] there is no need to assume 
a specific neurological pathology to explain the neu-
rological symptoms. These are sufficiently explained 
by a stringent application of the ideas on the patho-
mechanisms already put forward in our previous two 
hypothesis papers. In the following we will discuss in 
detail how they could affect the brain to produce the 
various neurological symptoms.
Decreased cerebral blood flow (CBF)
In the first two hypothesis papers we identified ß2AdR 
dysfunction, high sympathetic tone (stress), hypov-
olemia (preload failure), endothelial or vascular dysfunc-
tion, and an energetic disturbance in skeletal muscle as 
the main critical factors in the ME/CFS pathophysiology 
[39]. Meanwhile more evidence for endothelial dysfunc-
tion has accumulated. Altered endothelial dysfunction-
related microRNAs were found in plasma from ME/CFS 
patients recently [5]. In Covid-19 infection the endothe-
lium is severely affected and the disturbance seems to 
persist in post-Covid Syndrome (PCS) [8, 12, 20, 23, 34]. 
Particularly the finding of severe endothelial affection in 
Covid-19 and the persisting endothelial dysfunction cor-
roborates our hypothesis of a role of endothelial and vas-
cular dysfunction in the pathogenesis of PCS. Endothelial 
dysfunction may result in decreased CBF.
Patients with ME/CFS have a reduced absolute CBF 
[42]. Another very consistent finding is a decrease in CBF 
during orthostatic challenge (head-up tilt testing), i.e. 
after leaving the horizontal position. End-tilt CBF reduc-
tion was 7% in healthy controls versus 26% in ME/CFS, 
and a 24.5% decrease was decribed already after chang-
ing the position from supine to sitting in severe ME/
CFS. As a possible explanation for the orthostatic intol-
erance and the decrease in CBF we assume the presence 
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of both a strong vasoconstrictor effect mediated by an 
elevated sympathetic tone and weakened vasodilator 
influences, that occurred in particular by dysfunction 
of ß2AdR and other causes of endothelial and vascular 
dysfunction. Covid-19 seriously affects the endothelium 
and there is evidence of chronic endothelial dysfunction 
in the post-Covid-syndrome similar to that in ME/CFS 
[8]. ß2AdRs have vasodilator effects in the brain, skele-
tal muscle and the heart, a mechanism to increase blood 
flow during muscular activity (a functional unit with the 
brain steering and coordinating muscle activity and the 
heart providing the blood flow for both organs). Since 
orthostatic stress is permanent during human activi-
ties (standing and even sitting) it is the basic stressor to 
which all other forms of stress are additive. It can desen-
sitize ß2AdR and cause vasoconstrictor predominance 
by the α1-adrenergic effects that do not desensitize upon 
chronic stimulation in contrast to ß2AdR [39]. Chronic 
psychosocial stress itself can cause endothelial dysfunc-
tion and an increase in vasconstrictor mechanisms by 
functional and structural changes fixing the state of 
vasoconstriction (similar to the mechanisms that lead 
to fixed hypertension) [19, 43]. Endothelial dysfunction, 
which is clearly present in ME/CFS and PCS, has been 
found associated with cognitive impairment in different 
conditions, in the elderly as well as in children [13, 37]. 
Since the decrease in CBF already occurs after changing 
position from horizonal to sitting, orthostatic stress can 
be considered as the basic and permanent stressor dur-
ing human activities in the awake state. We think that a 
decrease in CBF by 25% already in a sitting position, a 
concomitantly disturbed neurovascular coupling and 
endothelial dysfunction will not allow enduring cogni-
tive efforts or mental work, with mental fatigue being the 
consequence.
Psychomotor slowing, ataxia and loss of coordination 
of movements in ME/CFS [7, 35] can also be explained 
by reduced perfusion, hypoperfusion of the motorcor-
tex and other structures involved in motor function not 
being able to maintain coordinated neuronal activity in 
the motor cortex, a disturbance similar to impaired cog-
nition. Since cognitive as well as motor function are dis-
turbed by reduced (global) CBF there is good reason to 
believe that other brain functions can also be disturbed 
as will be explained in the following.
Disturbed local blood flow regulation 
and neurovascular coupling
A reduction of global CBF is not the only cerebrovas-
cular finding in ME/CFS. Consistent observation of 
sluggish fMRI signals suggests abnormal neurovascu-
lar coupling meaning that local blood flow regulation 
is also disturbed [28, 29, 33]. Endothelial dysfunction 
may play a role in the disturbance of neurovascular 
coupling. The question is whether the inflammatory 
mediators released from skeletal muscle can also affect 
neurovascular coupling, the local regulation of blood 
flow adjusting local perfusion to local neurophysiologi-
cal activitiy. We think that influx of vasodilators, which 
otherwise also regulate local perfusion in other organs, 
into the cerebrovascular bed being under excessive 
vasoconstrictor influences via heightened sympathetic 
tone (stress), dysfunction of ß2AdR and endothelial 
dysfunction can only disturb a highly regulated fine 
tuning of vascular regulation and local blood distribu-
tion (neurovascular coupling).
Increase in intracranial presssure
A more recent finding is an increase in intracranial 
presssure based on neuroradiological signs in an MRI 
study. Signs of intracranial hypertension (IH) can be 
shown in 83% of the patients with ME/CFS [6]. A fur-
ther argument for a raised intracranial pressure is a 
higher prevalence of perineural or Tarlov cysts in the 
spinal cord in ME/CFS patients compared with healthy 
people [16]. These cysts are nerve root dilations result-
ing from pathologically increased cerebrospinal fluid 
pressure. They initially affect sensory neurons and 
axons in dorsal root ganglia and produce sensory symp-
toms consistent with paresthesias and radicular pain as 
does the increased cerebrospinal pressure itself. IH can 
also be a cause of headache [14]. A rise in intracranial 
pressure is at the expense of cerebral perfusion pres-
sure which may have the strongest effect at the level of 
capillary blood flow. Possibly for this reason, IH is also 
associated with cognitive impairment [14].
Hypoperfusion of skeletal muscle together with mito-
chondrial dysfunction leads to the excessive production 
of various endogenous vasodilators in skeletal mus-
cles and to their spillover into the systemic circulation, 
from where they can reach every organ including the 
brain [39]. One of these mediators, bradykinin, is the 
most potent opener of the blood brain barrier (BBB) [1, 
27] which may be of relevance for the neurological find-
ings and symptoms. Opening of the BBB may explain 
moderate IH for which we have provided the evidence 
above. We could not find in the literature what the 
symptoms of isolated opening of the BBB would be but 
we assume it to be rather pathological. The algesic and 
hyperalgesic properties of the tissue mediators released 
from skeletal muscles may cause headache by directly 
acting on cerebrovascular nociceptors, by the release of 
CGRP and substance P and by edematous distension. 
Headache could also originate from myalgia of head 
and neck muscles and from IH [14].
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Disturbances of reflexes and autonomic function, 
hypervigilance and hypersensitivity to sensory 
stimuli such as light, noises and smells and brain 
fog
Disturbances of the pupillary reflex [4] upon prolonged 
illumination of the pupils were also reported in patients 
with ME/CFS: “Two unusual responses were observed 
that are evident on prolonged illumination of the pupils. 
The more frequent finding seen in three quarters of 
patients is a rhythmic contraction and dilatation of the 
pupils. The second pattern is a paradoxical dilation of 
the pupils after an initial contraction.“ Thus, one should 
consider the possibility that also other regulatory mecha-
nisms of body and autonomic functions and reflexes, like 
orthostatic regulation, vascular regulation, thermoreg-
ulation and sleep are also impaired as a consequence 
of a reduced CBF. This could result in either sluggish 
responses to sudden changes or the opposite, namely 
large overshooting swings unable to find a new stable 
level of regulation after a disturbance, similar as observed 
with the pupillary reflex. In such a way impaired regula-
tion of orthostatic function may contribute to orthos-
tatic dysregulation and intolerance without necessarily 
being the main cause of it. Hence, dysautonomia may 
be enhanced by a disturbed CBF. Primary disturbances 
of the autonomic nervous system and dysautonomia or 
autonomic dysfunction arising from the brain stem may 
play a role in triggering ME/CFS for instance by ortho-
static dysfunction causing orthostatic stress that would 
desensitize ß2AdR and raise α-adrenergic mediated vaso-
constriction. Based on these considerations, it should 
be considered that ME/CFS itself could cause or at least 
worsen autonomic dysfunction by cerebral hypoperfu-
sion from which another vicious circle would arise. By 
these mechanisms autonomic dysfunction could also 
be expanded to other primarily undisturbed autonomic 
functions.
Neuroinflammation of the brain stem has been dis-
cussed as a possible cause of dysautonomia but no clear 
evidence has been provided so far [36]. If neuroinflam-
mation of the brain stem was the primary cause of dysau-
tonomia the question would still have to be answered of 
how such a disturbance could cause the myriad of symp-
toms and objective findings like muscle weakness, pH 
changes in skeletal muscles, PEM and cardiovascular 
findings like hypovolemia with low RAAS activity. Our 
“unifying” hypothesis allows to explain how dysautono-
mia independent of its primary cause can cause the myr-
iad of symptoms and enigmatic findings of ME/CFS.
Hypervigilance and sympathetic hyperactivity are pre-
sent in ME/CFS [10]. Stress may cause hypervigilance by 
centrally stimulatory effects of catecholamines and  PGE2 
(one of the mediators released into the circulation by the 
skeletal muscles). The latter has awakening effects [15]. 
The α2-adrenergic autoreceptor, a presynaptic recep-
tor on noradrenergic neurons modulating and inhibit-
ing norepinephrine release [26] shows desensitization [3] 
similar to the ß2AdR, but unlike α1-adrenergic receptors. 
Thus, chronic stress could also desensitize this inhibit-
ing autoreceptor to enhance catecholamine release in 
activating noradrenergic nuclei of the brain stem like the 
locus coeruleus thereby causing arousal and increased 
vigilance, and in the sympathetic nervous system leading 
to enhanced vasoconstrictor output while the vasodila-
tor ß2AdR is dysfunctional and endothelial dysfunction 
of other causes may be present. It would finally mean 
that chronic stress enhances stress responses (adrener-
gic hyperactivity). Orthostatic stress may play a particu-
lar role since it is already present in the sitting position 
in ME/CFS to decrease CBF and therefore almost una-
voidable. Since orthostatic stress is operative over a con-
siderable part of the day there is not sufficient time for 
recovery of desensitized adrenergic receptors. Episodes 
of stress in human life are usually followed by episodes of 
rest and recovery in which re-sensitization of adrenergic 
receptors can take place and therefore such enhancement 
of stress responses can fade if sufficient time of recovery 
is allowed (presumeably only few days of rest needed for 
receptor re-sensitization). In line with these considera-
tions, long and intense periods of psychosocial stress, in 
which such desensitization could take place, precede the 
development of ME/CFS in a subset of patients which is 
a potential explanation for the initiation of the disease 
in this subset. By the mechanisms outlined in our previ-
ous paper, ME/CFS, once fully established, is a state in 
which a high level of stress is maintained and fixed by a 
number of dysregulations and vicious circles, which the 
patient can hardly escape [40]. Since there is no recovery 
from stress in ME/CFS, α2-adrenergic autoreceptors and 
ß2AdR remain desensitized.
Possible desensitization of the α2-adrenergic recep-
tor (α2AdR) located in the noradrenergic nuclei and in 
cardiovascular centers of the medulla oblongata should 
be added to the possible brainstem pathomechanisms 
involved in dysautonomia. Dysfunction of the α2AdR 
autoreceptor could cause overshooting sympathetic 
responses by enhanced catecholamine release that may 
contribute to orthostatic dysregulation, cause distur-
bances of respiratory control (hyperventilation) and 
affect other autonomic functions.
Hypervigilance caused in the way just described may 
lead to increased stimulus uptake in all sensory organs 
while stimulus processing in the corresponding brain 
regions may be impaired by the reduced CBF as out-
lined above. Increased stimulus uptake and concomi-
tantly reduced stimulus processing may lead to stimulus 
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overload. Stimulus overload could be the cause of hyper-
sensitivities against sensory stimuli such as light, noises 
and smells.
These considerations also help to understand the 
simultaneous presence of signs of hypervigilance and 
mental fatigue in ME/CFS patients. This paradox can be 
explained by the discrepancy between the higher energy 
demand caused by neuronal overstimulation and the 
reduced energy supply by cerebral hypoperfusion result-
ing in an early energetic deficit to explain the high level 
of mental fatigability. The ability to perform mental work 
may be additionally diminished by hypervigilance (non-
specific overstimulation) reducing the ability to concen-
trate on a single mental task which may be part of the 
mechanisms causing the feeling of brain fog. Finally, brain 
fog may be the result of central overstimulation, cerebral 
hypoperfusion, IH and opening of the BBB allowing the 
endogenous mediators released from skeletal muscle like 
bradykinin and  PGE2 to exert effects in the brain.
Hypocapnia, hyperventilation, respiratory 
alkalosis and possible consequences for skeletal 
muscle metabolism
A frequent finding in ME/CFS and postural tachycardia 
syndrome (POTS), which is frequently associated with 
ME/CFS, is hypocapnia and hyperventilation [10, 35]. 
Hypocapnia causes cerebral vasoconstriction enhanc-
ing the effect of cerebral vasoconstriction induced by 
the sympathetic nervous system. In POTS it was shown 
that there is no fall in blood pressure,thus brain perfusion 
pressure is maintained [31]. Cerebral blood flow velocity 
of the middle cerebral artery was reduced during head‐up 
tilt associated with hyperventilation. Thus the decrease in 
CBF can be explained only by a rise in cerebrovascular 
resistance by vasoconstriction.
We consider hyperventilation, an overshooting 
response to a respiratory stimulus, resulting from auto-
nomic dysfunction with sympathetic overactivity. In PCS 
hyperventilation has recently been identified as cause of 
dyspnea. Hyperventilation occurred early during exer-
cise resulting in an impaired ventilatory efficiency [2, 
22]. The cause may be excessive stimulation of the res-
piratory center in the brain stem causing the feeling of 
air hunger (dyspnea). A physiological early mechanism 
of respiratory stimulation is via skeletal muscle afferents 
involving movement sensors and metabolic afferents 
[30]. It is obvious to incriminate a disturbed metabolic 
situation in skeletal muscle in this early, excessive stimu-
lation of respiration during exercise. The latter could then 
be further enhanced by dysautonomia (as an overshoot-
ing response). The resulting dyspnea is not only limiting 
the ability to exercise but aggravates the key pathophysi-
ological mechanisms in skeletal muscle in ME/CFS. 
Hyperventilation induced respiratory alkalosis is buffered 
by a shift of protons from the intracellular to the extracel-
lular space mainly via the NHE1 thereby loading the cells 
with sodium. Sodium overload in ME/CFS reversing the 
transport mode of the NCX to cause calcium overload 
is therefore not only the consequence of an insufficient 
 Na+/K+-ATPase-activity and a glycolytic metabolism 
but hyperventilation may contribute and worsen it. Alto-
gether, dysautonomia together with the disturbed skeletal 
muscle metabolism may cause hyperventilation and res-
piratory alkalosis—at least during exercise—and thereby 
further disturb the skeletal muscle metabolic situation by 
sodium- and calcium- overload (vicious circle).
Sleep disturbances and non‑restorative sleep
Difficulties to fall asleep and altered day-night rhythm 
may result directly from enhanced catecholamine release 
in activating noradrenergic nuclei of the brain stem 
like the locus coeruleus as a consequence of desensi-
tized α2-autoreceptors and stress causing arousal and 
increased vigilance. Stimulus overload just explained 
above could be an indirect cause of sleep disturbances. 
In sleep medicine it is considered an important cause of 
insomnia.
Sleep quality may also be affected by disturbed noc-
turnal breathing and respiratory disturbances. Hypocap-
nia and hyperventilation are frequently found in ME/
CFS during wakefulness [10, 35]. Patients with whiplash 
injury, who frequently suffer from ME/CFS, also present 
with hyperventilation [39]. Hypocapnia as a consequence 
of hyperventilation has destabilizing effects on breath-
ing during sleep to mainly cause central apneas (due to 
the existence of the  CO2-apneic threshold) [38]. The key 
question is whether hyperventilation and hypocapnia 
also occur during sleep in ME/CFS which has not yet 
been investigated. It is rather unlikely that a respiratory 
disturbance present in the awake state at rest will disap-
pear with sleep onset. This is because the so-called wake-
fulness drive to breathe has a stabilizing effect so that 
breathing usuallys gets even more unstable during sleep 
[9]. Even mild sleep-related breathing disorders in ME/
CFS would have the potential to make sleep another big 
stressor and to severely affect the general health condi-
tion of ME/CFS patients. Since the destabilizing effect of 
hyperventilation and hypocapnia on nocturnal breathing 
is strong and well established [9] and since the conse-
quences of intermittent hypoxia with the ensuing sym-
pathetic surges could be much more severe in ME/CFS 
compared with sleep apnea patients, the negative con-
sequences could even appear at lower levels of hypoxia 
and oxygen desaturation. Due to the predominance 
of vasoconstrictor over vasodilator influences sympa-
thetic surges arising from intermittent hypoxia in the 
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post-apneic phase would probably much more severely 
affect perfusion of the brain and skeletal muscles in 
patients with ME/CFS than in patients with sleep apnea 
only. During sleep this could lead to the compensatory 
release of endogenous algesic vasodilators from skeletal 
muscles and spillover into the systemic circulation as 
already postulated for exercise and stress situations in the 
awake state. This could further disturb sleep since  PGE2 
has awakening effects [15]. It could also further disturb 
nocturnal breathing as upper and lower airway (bron-
chial) resistance may be raised due to edema (microvas-
cular leakage) and the spasmogenic effect of mediators 
like  PGE2 and bradykinin in the bronchi.
Poor sleep can certainly worsen fatigue and symptoms 
in ME/CFS, but even a perfect sleep could not abol-
ish mental and skeletal muscle fatigue because the main 
causes of fatigue are unrelated to sleep. Mental and mus-
cular fatigue are related to insufficient blood flow and, 
concerning skeletal muscle fatigue, there is an additional 
energetic disturbance, namely mitochondrial dysfunc-
tion. At least the term “non-restorative sleep “ should 
therefore be used with caution and in the knowledge that 
disturbed sleep may worsen fatigue but it is not the main 
cause of it.
Conclusion
Neurological symptoms in ME/CFS can be severe and 
debilitiating, but no clear specific brain pathology or 
lesions have been detected so far. Whether neuroin-
flammation or a brain stem pathology exists—where 
dysautonomia may have its origin as the primary dis-
turbance eliciting ME/CFS—remains to be shown [36]. 
Decreased CBF, disturbed local blood flow regulation 
and neurovascular coupling, central adrenergic hyperac-
tivity, hypocapnia and increase in intracranial presssure 
seem to play a strong role in the pathophysiology of the 
neurological symptoms in ME/CFS (Fig.  1). They can 
well explain cognitive impairment, brain fog, headache, 
psychomotor slowing, ataxia and loss of coordination 
of movements, hypersensitivity, sleep disturbances and 
dysautonomia.
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